The work of our investigators touches every type of childhood cancer. Through our research, we're finding ways to improve quality of life for cancer survivors.
Researchers are developing and clinically validating psychosocial assessment tools and mHealth intervention strategies to improve medical, developmental and psychological outcomes for AYA cancer patients and their families.
Research into cancer genetics and genomics can help improve cancer diagnosis and aid in the development of new therapies for children with cancer.
Researchers are using the latest advances in oncology, molecular biology and genomic analyses to provide care and counseling to children with genetic predispositions to cancer.
Investigators are quickly translating basic research discoveries into promising new treatment options for children with cancer.
Modern molecular and immunological approaches are being applied to develop and optimize treatments for infants and children with hematologic malignancies.
Investigators at the Center for Childhood Cancer Research are using genomic, immunotherapeutic and targeted cancer therapy approaches to develop new treatments for children with spinal cord and brain tumors.
Researchers are developing new treatment regimens and optimizing those that already exist to treat infants and children with neuroblastoma.
Investigators at the Center for Childhood Cancer Research are developing and clinically evaluating new treatment options for children with solid tumors, including targeted cancer agents and immunotherapies.
Investigators are applying behavioral translational research to improve psychosocial outcomes and quality of life for children and adolescents with cancer.
Cancer pathobiology is an integrative discipline seeking insights into molecular and cellular mechanisms responsible for all aspects of cancerous growth.
Investigators at the Center for Childhood Cancer Research are developing programs and interventional strategies to identify, treat and manage therapy-related late effects experienced by survivors of childhood cancer and their families.
Researchers at the Center for Childhood Cancer Research have developed fertility preservations options for male and female children who may be at risk for impaired or lost fertility after cancer treatment.
Researchers are using molecular biological and immunotherapeutic approaches to better define the relationship between LCH and cancer and to develop new safe and effective treatment options for children with LCH.
Investigators at the Center for Childhood Cancer Research are catalyzing the incorporation of research advancements into routine clinical care for children with relapsed or refractory neuroblastoma.
Researchers are using modern clinical and technological approaches to improve existing treatment regimens and develop new or alternative therapies to treat children with retinoblastoma.
Researchers are using both clinical and basic science approaches to improve the diagnosis, treatment and health of children with thyroid cancer.